Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep Learning-Enabled Exploration of Predictive Signatures in a Multicenter Retrospective and Prospective Observational Study Allowing the Analysis of the Aggregation of Multimodal Clinical, Biological, Genomic and Radiomics Data Associated With the Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer

NCT04994795 is registered in ClinicalTrials.gov with Sophia Genetics SAS as lead sponsor.

NCT NCT04994795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04994795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deep Learning-Enabled Exploration of Predictive Signatures in a Multicenter Retrospective and Prospective Observational Study Allowing the Analysis of the Aggregation of Multimodal Clinical, Biological, Genomic and Radiomics Data Associated With the Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer
Lead sponsor
Sophia Genetics SAS
Phase
Observational
Overall status
Active, not recruiting
Start date
August 21, 2021
Completion date
February 28, 2025
Enrollment
4,000 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer metastatic